Skip to main content

Advertisement

Log in

Churg-Strauss syndrome associated with the leukotriene antagonist montelukast

  • CASE REPORT
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

Churg-Strauss syndrome (CSS) is a disseminated small vessel vasculitis characterized by late-onset asthma, upper airways disease, eosinophilia and late neurological manifestations such as peripheral neuropathy. Recently, several cases of CSS have been reported in patients treated with leukotriene antagonists after weaning corticosteroids. We describe a case of CSS developed while the patient was receiving montelukast for asthma treatment, after corticosteroids withdrawal. A causal relationship between montelukast therapy and CSS is hypothesized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Boccagni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boccagni, C., Tesser, F., Mittino, D. et al. Churg-Strauss syndrome associated with the leukotriene antagonist montelukast. Neurol Sci 25, 21–22 (2004). https://doi.org/10.1007/s10072-004-0221-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-004-0221-y

Key words

Navigation